M L Willoughby. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdolescentAdultAntineoplastic Agents/therapeutic useBlood TransfusionBloodlettingCell CountCyclophosphamide/therapeutic useCytosine/therapeutic useDaunorubicin/therapeutic useDrug Therapy, CombinationGraft vs Host Reaction/radiation effectsHumansLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/immunologyLeukemia, Myeloid, Acute/therapyLeukocytes/radiation effectsLife ExpectancyMiddle AgedMitosis/drug effectsPrednisolone/therapeutic usePrednisone/therapeutic useRemission, SpontaneousThioguanine/therapeutic useVincristine/therapeutic use
Substances: See more » Antineoplastic AgentsVincristineCytosineCyclophosphamidePrednisoloneThioguaninePrednisoneDaunorubicin
Year: 1974 PMID: 4154793 PMCID: PMC1612881 DOI: 10.1136/bmj.4.5940.337
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447